Regal Investment Advisors »

Werewolf Therapeutics shares owned by Regal Investment Advisors

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Regal Investment Advisors from 13F filings

Historical chart of Regal Investment Advisors investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Regal Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Regal Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $31k 15k 2.12

More positions owned by Regal Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Abbvie (ABBV)
Ishares Tr Core Total Usd (IUSB)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Procter & Gamble Company (PG)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Johnson & Johnson (JNJ)

View all positions for Regal Investment Advisors

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Partner Fund Management
MPM Oncology Impact Management
Bank of America Corporation
BlackRock
BlackRock
Rubric Capital Management
Vanguard Group
Eagle Health Investments
Geode Capital Management
Sphera Funds Management
DC Funds
State Street Corporation
Acadian Asset Management

View all funds holding Werewolf Therapeutics